secured the entire supply of remdesivir, an antiviral drug that shortens hospital stays for COVID-19 patients, until September.In March, there were reports that Donald Trump’s administration tried to buy a German company working on a COVID-19 vaccine in order to secure the entire supply for the U.S.
A group formed by France, Germany, Italy and the Netherlands struck a deal in the past few weeks to secure 400 million doses of AstraZeneca’s potential vaccine, although other countries are also encouraged to join the group on the same terms.
Whether poor countries could afford the terms is another question.It certainly doesn’t seem that “we’re all in this together” — it’s looking more and more like a dog-eat-dog world.